| |
Blood, Vol. 103, No. 4. (15 February 2004), pp. 1342-1347.
|
| |
Prostaglandins, Leukotrienes and Essential Fatty Acids, Vol. 78, No. 3. (March 2008), pp. 209-217.
|
| |
Biochemical and biophysical research communications, Vol. 380, No. 3. (13 March 2009), pp. 437-441.
|
| |
Experimental and molecular pathology, Vol. 73, No. 1. (August 2002), pp. 1-8.
|
| |
Endocrinology, Vol. 138, No. 7. (1 July 1997), 3073.
|
| |
Journal of Inflammation, Vol. 4, No. 1. (26 September 2007), 20.
|
| |
Clinical science (London, England : 1979) (5 March 2009)
|
| |
Current opinion in pharmacology, Vol. 6, No. 2. (April 2006), pp. 125-129.
|
| |
FASEB J. (29 April 2005), 04-3583fje.
|
| |
Journal of the American College of Surgeons, Vol. 190, No. 4. (April 2000), pp. 423-431.
|
| |
Diabetes, Vol. 56, No. 7. (July 2007), pp. 1761-1772.
by P. D. Cani, J. Amar, M. A. Iglesias, et al.M. Poggi, C. Knauf, D. Bastelica, A. M. Neyrinck, F. Fava, K. M. Tuohy, C. Chabo, A. Waget, E. Delmée, B. Cousin, T. Sulpice, B. Chamontin, J. Ferrières, J. F. Tanti, G. R. Gibson, L. Casteilla, N. M. Delzenne, M. C. Alessi, R. Burcelin
|
| |
Br J Pharmacol, Vol. 146, No. 4. (2005), pp. 498-505.
|